About: Mineralocorticoid Receptor Antagonist Reduces Renal Injury in Rodent Models of Types 1 and 2 Diabetes Mellitus

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Mineralocorticoid Receptor Antagonist Reduces Renal Injury in Rodent Models of Types 1 and 2 Diabetes Mellitus Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 10 August 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2006 (fr) наукова стаття, опублікована в листопаді 2006 (uk) im November 2006 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 10 August 2006 (en) 2006 թվականի օգոստոսի 10-ին հրատարակված գիտական հոդված (hy) artículu científicu espublizáu n'agostu de 2006 (ast)
publication date	wds:Q61636758-E727A7E6-4447-4D3C-B6AC-A7395A7DDDFD
publication date	2006-08-10 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q61636758-D631EEB8-0572-4839-BA76-7BA5125CA11B
language of work or name	English
cites work	wds:Q61636758-25B82A72-7EA3-444E-841E-238539D136AA
cites work	The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study
author name string	wds:Q61636758-0F2FF27F-17D8-47EE-B99E-DB01CFFC9ED4 wds:Q61636758-30CC0B35-DBE8-49DF-AF1E-FB071B9CDE00 wds:Q61636758-54065159-EEAE-46FB-8822-D15B113A81F7 wds:Q61636758-621FC881-1FC9-48C7-A6AA-957619453C22 wds:Q61636758-75CFBCAA-DA64-493D-89E3-D22FEC51A513 wds:Q61636758-A6AD87A2-3AC2-45E0-A7FF-6AAAB4388B95 wds:Q61636758-BD4EBE36-BB48-415A-A448-FE9B570A3822 wds:Q61636758-D8781C19-F1DA-4E81-A661-6FB78D6F1536 wds:Q61636758-EBEC1A62-594B-4BF9-A8EC-12AA68057074 wds:Q61636758-EC182D96-33C7-4B5C-858B-2903178B17B9 wds:Q61636758-F1B8F8FA-F09F-4F56-B31B-903F43E94C49
author name string	Gordon H Williams Gail K Adler Nathalie Lapointe Tham M Yao Vincent Ricchiuti Christine Guo Diego Martinez-Vasquez Eveline M Oestreicher Luminita Pojoga Maria F Toniolo Taisuke Kikuchi
rdfs:label	Mineralocorticoid Receptor Antagonist Reduces Renal Injury in Rodent Models of Types 1 and 2 Diabetes Mellitus (en) Mineralocorticoid Receptor Antagonist Reduces Renal Injury in Rodent Models of Types 1 and 2 Diabetes Mellitus (nl)
skos:prefLabel	Mineralocorticoid Receptor Antagonist Reduces Renal Injury in Rodent Models of Types 1 and 2 Diabetes Mellitus (en) Mineralocorticoid Receptor Antagonist Reduces Renal Injury in Rodent Models of Types 1 and 2 Diabetes Mellitus (nl)
name	Mineralocorticoid Receptor Antagonist Reduces Renal Injury in Rodent Models of Types 1 and 2 Diabetes Mellitus (en) Mineralocorticoid Receptor Antagonist Reduces Renal Injury in Rodent Models of Types 1 and 2 Diabetes Mellitus (nl)
author	wds:Q61636758-FE53D1BD-7470-4D49-B356-E246983FA5FD
author	Gonzalo R Méndez
title	wds:Q61636758-CE40AB9A-421B-4674-92B1-5797367B44A4
title	Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus (en)
page(s)	wds:Q61636758-47104C4E-9674-4560-8FA3-2A537D6A4326
page(s)	5363-5373
instance of	wds:Q61636758-5F71E2C6-898E-4A1A-B819-91213148F241
instance of	scholarly article
PubMed ID	wds:Q61636758-C3313D7F-2F6C-425D-A519-635B303A3A25
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16901964
PubMed ID	16901964
published in	wds:Q61636758-25E17878-61C2-4284-9D9E-5D8784F0918B
published in	Endocrinology
issue	wds:Q61636758-80FEF4CF-0D1E-46FD-BD44-63A4892F3B88
volume	wds:Q61636758-AB30AC7D-6724-454A-84D4-04E5FEEE32E3
issue	11
volume	147
DOI	wds:Q61636758-5CFAABF8-7F76-4663-8ADF-90866F3C25D6
DOI	http://dx.doi.org/10.1210/EN.2006-0944
DOI	10.1210/EN.2006-0944
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q61636758
is cites work of	The ubiquitous mineralocorticoid receptor: clinical implications Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects Mineralocorticoid receptor throughout the vessel: a key to vascular dysfunction in obesity Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice Cortisol stimulates proliferation and apoptosis in the late gestation fetal heart: differential effects of mineralocorticoid and glucocorticoid receptors Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy Spironolactone inhibits apoptosis in rat mesangial cells under hyperglycaemic conditions via the Wnt signalling pathway Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II. Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update Salt, the renin-angiotensin-aldosterone system and resistant hypertension Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin Tofogliflozin, a novel sodium-glucose co-transporter 2 inhibitor, improves renal and pancreatic function in db/db mice. Cardiovascular and autonomic phenotype of db/db diabetic mice Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats. The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomeru-lonephritis Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice Drug Insight: eplerenone, a mineralocorticoid-receptor antagonist Hypertension and disrupted blood pressure circadian rhythm in type 2 diabetic db/db mice Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome Critical Role of Striatin in Blood Pressure and Vascular Responses to Dietary Sodium Intake Effects of mineralocorticoid receptor antagonists on the progression of diabetic nephropathy Spironolactone improves endothelial dysfunction in streptozotocin-induced diabetic rats Mineralocorticoid receptor activation as an etiological factor in kidney diseases Long-term dietary sodium restriction increases adiponectin expression and ameliorates the proinflammatory adipokine profile in obesity Aldosterone's rapid, nongenomic effects are mediated by striatin: a modulator of aldosterone's effect on estrogen action The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy Randomized Controlled Trial of Mineralocorticoid Receptor Blockade in Children with Chronic Kidney Allograft Nephropathy Myeloid mineralocorticoid receptor activation contributes to progressive kidney disease.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software